Abiopharma

News list

Urist Marshall 🟢 acquired 18.2K shares of Royalty Pharma plc (RPRX) Transaction Date: May 06, 2026 | Filing ID: 000014

Full text

News bot May 8, 2026, 9:11 p.m.
🔍 Urist Marshall (Executive)

Company: Royalty Pharma plc (RPRX)

Report Date: 2026-05-06
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 18,197
- Total shares held: 19,020
Detailed Transactions and Holdings:
- Acquired 18,197 shares of Class A Ordinary Shares (Direct)
  Date: 2026-05-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 45,565.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Class A Ordinary Shares (Direct)
  Date: 2026-05-06 | Code: H | nature_of_ownership: By IRA | shares_owned_after: 19,020.00
Footnotes:
- F1: Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.
- REMARKS: In addition to the Class A Ordinary Shares disclosed above, the Reporting Person and family vehicles controlled by the Reporting Person hold limited partnership interests in RPI US Partners 2019, LP exchangeable into 2,474,120 Class A Ordinary Shares and Class E Ordinary Shares of Royalty Pharma Holdings Ltd ("RPH") exchangeable into 1,356,528 Class A Ordinary Shares. Class E Ordinary Shares of RPH are subject to vesting conditions.